A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B

NCT01125657 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Pharmacokinetics of YM150

Interventions

DRUG: YM150

Sponsor

Astellas Pharma Inc